The prevention of cardiovascular disease worldwide: whose task and WHO's task?

Author： Poole-Wilson Philip  

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.5, Iss.4, 2005-07, pp. : 379-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recommendations against the use of betacarotene supplements for the prevention of cardiovascular disease or cancer have been published by the US Preventive Services Task Force

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pharmaceutical thrombosis prevention in cardiovascular disease

By Eriksson Mats   Christensen Kjeld   Lindahl Tomas L   Larsson Anders  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 553-563

Informa Healthcare

Access to resources Recommend Favorite

Lipid Management for the Prevention of Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite

Garlic for Cardiovascular Disease: Prevention or Treatment?

By  

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1028-1041

Bentham Science Publishers

Access to resources Recommend Favorite

Using HPV vaccine for cervical cancer prevention: not an easy task

By  

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite